-
10008640-1The Cayman Asthma Treatment Standard Set contains three potent, selective Cysteinyl Leukotriene (CysLT) 1 receptor antagonists (10 mg each) currently used clinically for the treatment of asthma. Zafirlukast and Montelukast (sodium salt), sold under
-
16677-1A bioactive saponin used in traditional Chinese medicine has diverse protective effects for the cardiovascular, immune, digestive, and nervous systems.
-
16677-10A bioactive saponin used in traditional Chinese medicine has diverse protective effects for the cardiovascular, immune, digestive, and nervous systems.
-
16677-5A bioactive saponin used in traditional Chinese medicine has diverse protective effects for the cardiovascular, immune, digestive, and nervous systems.
-
16677-50A bioactive saponin used in traditional Chinese medicine has diverse protective effects for the cardiovascular, immune, digestive, and nervous systems.
-
20133-2.5An antibiotic that inhibits growth in various tumor cell lines (IC<sub>50</sub>s = 1-5 µM) by activating caspases 8 and 3.
-
20133-500An antibiotic that inhibits growth in various tumor cell lines (IC<sub>50</sub>s = 1-5 µM) by activating caspases 8 and 3.
-
19929-1An orally bioavailable Smac/DIABLO mimetic and antagonist of IAPs (Kis = 66.4, 1.
-
19929-10An orally bioavailable Smac/DIABLO mimetic and antagonist of IAPs (Kis = 66.4, 1.
-
19929-5An orally bioavailable Smac/DIABLO mimetic and antagonist of IAPs (Kis = 66.4, 1.
-
19929-500An orally bioavailable Smac/DIABLO mimetic and antagonist of IAPs (Kis = 66.4, 1.
-
13160-1A selective, competitive, and highly bioavailable inhibitor of L-PGDS (Ki = 75 µM) inhibits the production of PGD2 by L-PGDS-expressing cells purified from human CSF and recombinant mouse with an IC<sub>50</sub> value of 95 µM.